Dacula, Sittie Alisha A.
HRN: 21-57-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/25/2022
08/31/2022
IV
30mg
OD
Necrotizing Enterocolitis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes